Non-invasive monitoring of alternative splicing outcomes to identify candidate therapies for myotonic dystrophy type 1

During drug development, tissue samples serve as indicators of disease activity and pharmacodynamic responses. Reliable non-invasive measures of drug target engagement will facilitate identification of promising new treatments. Here we develop and validate a novel bi-transgenic mouse model of myoton...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Ningyan, Antoury, Layal, Baran, Timothy M., Mitra, Soumya, Bennett, C. Frank, Rigo, Frank, Foster, Thomas H., Wheeler, Thurman M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286378/
https://www.ncbi.nlm.nih.gov/pubmed/30531949
http://dx.doi.org/10.1038/s41467-018-07517-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286378/
https://www.ncbi.nlm.nih.gov/pubmed/30531949
http://dx.doi.org/10.1038/s41467-018-07517-y

Ejemplares similares